Oncology Nutrition Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Oncology nutrition refers to the nutrition and diet of cancer patients who are undergoing treatment or have completed treatment. Nutrition is a vital supportive therapy during cancer treatment and plays a significant role in several areas of cancer development. Appropriate diet can help cancer patients in maintaining their weight and body composition, resulting in improved recovery and a better quality of life. For a cancer patient, proper nutrition gives them the strength they need to combat the disease. The right nutrition can help a patient cope with the unpleasant side effects of cancer and its therapy. Good nutrition also helps in speedy recovery of cancer patients.
MARKET SCOPE
The "Global Oncology Nutrition Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the oncology nutrition market with detailed market segmentation by cancer type. The report provides key statistics on the market status of the leading oncology nutrition market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on cancer type the market is segmented as, Head and Neck Cancers, Stomach and Gastrointestinal Cancers, , Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer and Other Cancers.
Drivers:
- Increasing prevalence of cancers and metastatic diseases is the key driver for the market growth.
- Growing demand for oncology nutrition for cancer patients, growing focus on eternal nutrition.
- Rising awareness regarding proper nutrition of cancer patients during their treatments.
- However, tube feeding-related complications and limited reimbursement associated with this are expected to restrain market growth during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The oncology nutrition market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the oncology nutrition market in these regions.
IMPACT OF COVID-19 ON ONCOLOGY NUTRITION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. The demand for oncology nutrition has decreased because of ongoing pandemic situation. The people cannot receive their cancer treatment by visiting hospitals due to restrictions imposed. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The oncology nutrition market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the oncology nutrition market in these regions.
IMPACT OF COVID-19 ON ONCOLOGY NUTRITION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. The demand for oncology nutrition has decreased because of ongoing pandemic situation. The people cannot receive their cancer treatment by visiting hospitals due to restrictions imposed. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the oncology nutrition market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from oncology nutrition market are anticipated to lucrative growth opportunities in the future with the rising demand for oncology nutrition in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the oncology nutrition market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- Nestle S.A.
- Nutricia
- Fresenius Kabi India Pvt. Ltd
- B. Braun Melsungen AG
- Mead Johnson Nutrition Company
- Hormel Foods Corporation
- Meiji Holdings Co., Ltd.
- Victus, Inc
- Global Health Products, Inc.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncology Nutrition Market - By Cancer type
1.3.2 Oncology Nutrition Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONCOLOGY NUTRITION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ONCOLOGY NUTRITION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONCOLOGY NUTRITION MARKET - GLOBAL MARKET ANALYSIS
6.1. ONCOLOGY NUTRITION - GLOBAL MARKET OVERVIEW
6.2. ONCOLOGY NUTRITION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ONCOLOGY NUTRITION MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
7.1. OVERVIEW
7.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEAD AND NECK CANCERS
7.3.1. Overview
7.3.2. Head and Neck Cancers Market Forecast and Analysis
7.4. STOMACH AND GASTROINTESTINAL CANCERS
7.4.1. Overview
7.4.2. Stomach and Gastrointestinal Cancers Market Forecast and Analysis
7.5. LUNG CANCER
7.5.1. Overview
7.5.2. Lung Cancer Market Forecast and Analysis
7.6. BREAST CANCER
7.6.1. Overview
7.6.2. Breast Cancer Market Forecast and Analysis
7.7. BLOOD CANCER
7.7.1. Overview
7.7.2. Blood Cancer Market Forecast and Analysis
7.8. OTHER CANCERS
7.8.1. Overview
7.8.2. Other Cancers Market Forecast and Analysis
8. ONCOLOGY NUTRITION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Oncology Nutrition Market Overview
8.1.2 North America Oncology Nutrition Market Forecasts and Analysis
8.1.3 North America Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.1.4 North America Oncology Nutrition Market Forecasts and Analysis - By Countries
8.1.4.1 United States Oncology Nutrition Market
8.1.4.1.1 United States Oncology Nutrition Market by Cancer type
8.1.4.2 Canada Oncology Nutrition Market
8.1.4.2.1 Canada Oncology Nutrition Market by Cancer type
8.1.4.3 Mexico Oncology Nutrition Market
8.1.4.3.1 Mexico Oncology Nutrition Market by Cancer type
8.2. EUROPE
8.2.1 Europe Oncology Nutrition Market Overview
8.2.2 Europe Oncology Nutrition Market Forecasts and Analysis
8.2.3 Europe Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.2.4 Europe Oncology Nutrition Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Oncology Nutrition Market
8.2.4.1.1 Germany Oncology Nutrition Market by Cancer type
8.2.4.2 France Oncology Nutrition Market
8.2.4.2.1 France Oncology Nutrition Market by Cancer type
8.2.4.3 Italy Oncology Nutrition Market
8.2.4.3.1 Italy Oncology Nutrition Market by Cancer type
8.2.4.4 Spain Oncology Nutrition Market
8.2.4.4.1 Spain Oncology Nutrition Market by Cancer type
8.2.4.5 United Kingdom Oncology Nutrition Market
8.2.4.5.1 United Kingdom Oncology Nutrition Market by Cancer type
8.2.4.6 Rest of Europe Oncology Nutrition Market
8.2.4.6.1 Rest of Europe Oncology Nutrition Market by Cancer type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Oncology Nutrition Market Overview
8.3.2 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis
8.3.3 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.3.4 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Oncology Nutrition Market
8.3.4.1.1 Australia Oncology Nutrition Market by Cancer type
8.3.4.2 China Oncology Nutrition Market
8.3.4.2.1 China Oncology Nutrition Market by Cancer type
8.3.4.3 India Oncology Nutrition Market
8.3.4.3.1 India Oncology Nutrition Market by Cancer type
8.3.4.4 Japan Oncology Nutrition Market
8.3.4.4.1 Japan Oncology Nutrition Market by Cancer type
8.3.4.5 South Korea Oncology Nutrition Market
8.3.4.5.1 South Korea Oncology Nutrition Market by Cancer type
8.3.4.6 Rest of Asia-Pacific Oncology Nutrition Market
8.3.4.6.1 Rest of Asia-Pacific Oncology Nutrition Market by Cancer type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Oncology Nutrition Market Overview
8.4.2 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis
8.4.3 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.4.4 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Oncology Nutrition Market
8.4.4.1.1 South Africa Oncology Nutrition Market by Cancer type
8.4.4.2 Saudi Arabia Oncology Nutrition Market
8.4.4.2.1 Saudi Arabia Oncology Nutrition Market by Cancer type
8.4.4.3 U.A.E Oncology Nutrition Market
8.4.4.3.1 U.A.E Oncology Nutrition Market by Cancer type
8.4.4.4 Rest of Middle East and Africa Oncology Nutrition Market
8.4.4.4.1 Rest of Middle East and Africa Oncology Nutrition Market by Cancer type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Oncology Nutrition Market Overview
8.5.2 South and Central America Oncology Nutrition Market Forecasts and Analysis
8.5.3 South and Central America Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.5.4 South and Central America Oncology Nutrition Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Oncology Nutrition Market
8.5.4.1.1 Brazil Oncology Nutrition Market by Cancer type
8.5.4.2 Argentina Oncology Nutrition Market
8.5.4.2.1 Argentina Oncology Nutrition Market by Cancer type
8.5.4.3 Rest of South and Central America Oncology Nutrition Market
8.5.4.3.1 Rest of South and Central America Oncology Nutrition Market by Cancer type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. ONCOLOGY NUTRITION MARKET, KEY COMPANY PROFILES
10.1. ABBOTT
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. NESTLE S.A.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. NUTRICIA
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. FRESENIUS KABI INDIA PVT. LTD
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. B. BRAUN MELSUNGEN AG
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. MEAD JOHNSON NUTRITION COMPANY
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. HORMEL FOODS CORPORATION
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. MEIJI HOLDINGS CO., LTD.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. VICTUS, INC
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. GLOBAL HEALTH PRODUCTS, INC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. Abbott
2. Nestle S.A.
3. Nutricia
4. Fresenius Kabi India Pvt. Ltd
5. B. Braun Melsungen AG
6. Mead Johnson Nutrition Company
7. Hormel Foods Corporation
8. Meiji Holdings Co., Ltd.
9. Victus, Inc
10. Global Health Products, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.